1. ANXA2 and Rac1 negatively regulates autophagy and osteogenic differentiation in osteosarcoma cells to confer CDDP resistance
    Baolong Pan et al, 2023, Biochemical and Biophysical Research Communications CrossRef
  2. Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation
    Mehrdad Hashemi et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
  3. Photothermal-triggered immunogenic nanotherapeutics for optimizing osteosarcoma therapy by synergizing innate and adaptive immunity
    Kaiyuan Liu et al, 2022, Biomaterials CrossRef
  4. Autophagy and its role in osteosarcoma
    Biao Ning et al, 2023, Cancer Medicine CrossRef
  5. Blocking CXCR4–CARM1–YAP axis overcomes osteosarcoma doxorubicin resistance by suppressing aerobic glycolysis
    Zihua Li et al, 2024, Cancer Science CrossRef
  6. CXCR4 as a therapeutic target in acute myeloid leukemia
    Jan Korbecki et al, 2024, Leukemia CrossRef
  7. The Targeted Therapies for Osteosarcoma via Six Major Pathways
    Shuxing Wang et al, 2023, Current Molecular Pharmacology CrossRef
  8. Blockade of CXCR4 promotes macrophage autophagy through the PI3K/AKT/mTOR pathway to alleviate coronary heart disease
    Fangqin Li et al, 2023, International Journal of Cardiology CrossRef
  9. Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma
    Yubo Xiang et al, 2023, Frontiers in Oncology CrossRef
  10. Engineering Bimetallic Polyphenol for Mild Photothermal Osteosarcoma Therapy and Immune Microenvironment Remodeling by Activating Pyroptosis and cGAS‐STING Pathway
    Kaiyuan Liu et al, 2024, Advanced Healthcare Materials CrossRef
  11. New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis
    Mehrdokht Sadrkhanloo et al, 2023, Pathology - Research and Practice CrossRef
  12. HIF‐1α mediates CXCR4 transcription to activate the AKT/mTOR signaling pathway and augment the viability and migration of activated B cell‐like diffuse large B‐cell lymphoma cells
    Zhen Jin et al, 2023, Molecular Carcinogenesis CrossRef
  13. CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas
    Anna C. Virgili et al, 2024, Diagnostics CrossRef